RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.7B
1-Year Est. Return 93.03%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+93.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.7B
AUM Growth
-$252M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
107
New
Increased
Reduced
Closed

Top Buys

1
+$17.4M
2
+$15M
3
+$9.3M
4
HTFL
Heartflow Inc
HTFL
+$8M
5
PTCT icon
PTC Therapeutics
PTCT
+$7.08M

Top Sells

1
+$61.1M
2
+$45.3M
3
+$27.4M
4
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$24M
5
TVTX icon
Travere Therapeutics
TVTX
+$21.9M

Sector Composition

1 Healthcare 99.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RVMD icon
1
Revolution Medicines
RVMD
$33.5B
$118M 6.93%
1,209,465
-125,805
LLY icon
2
Eli Lilly
LLY
$985B
$90.8M 5.35%
98,700
-6,700
MDGL icon
3
Madrigal Pharmaceuticals
MDGL
$11.5B
$89.5M 5.28%
170,999
+31,381
MIRM icon
4
Mirum Pharmaceuticals
MIRM
$6.19B
$74.9M 4.42%
811,294
+49,000
ARGX icon
5
argenx
ARGX
$52B
$71.9M 4.24%
98,500
-4,750
RYTM icon
6
Rhythm Pharmaceuticals
RYTM
$6.05B
$60M 3.54%
689,748
-5,262
INSM icon
7
Insmed
INSM
$23.2B
$51.4M 3.03%
314,300
-4,950
ASND icon
8
Ascendis Pharma A/S
ASND
$13.8B
$44.4M 2.62%
194,000
-9,500
XENE icon
9
Xenon Pharmaceuticals
XENE
$5.29B
$44.4M 2.62%
763,020
-24,768
TVTX icon
10
Travere Therapeutics
TVTX
$4.39B
$43.9M 2.59%
1,477,954
-732,368
KYMR icon
11
Kymera Therapeutics
KYMR
$6.7B
$41.4M 2.44%
496,871
PEN icon
12
Penumbra
PEN
$12.5B
$39.6M 2.33%
120,500
ISRG icon
13
Intuitive Surgical
ISRG
$150B
$37.8M 2.23%
82,000
SRRK icon
14
Scholar Rock
SRRK
$5.91B
$36.4M 2.14%
739,816
+6,339
ELVN icon
15
Enliven Therapeutics
ELVN
$2.41B
$32.4M 1.91%
826,500
+28,095
BSX icon
16
Boston Scientific
BSX
$71.8B
$32.3M 1.91%
515,300
+116,250
IRTC icon
17
iRhythm Holdings
IRTC
$3.74B
$30.9M 1.82%
261,750
+26,750
GPCR icon
18
Structure Therapeutics
GPCR
$2.8B
$30.9M 1.82%
640,217
-108,019
AGIO icon
19
Agios Pharmaceuticals
AGIO
$1.75B
$27M 1.59%
799,163
RARE icon
20
Ultragenyx Pharmaceutical
RARE
$2.36B
$25.5M 1.5%
1,218,773
-48,468
ALNY icon
21
Alnylam Pharmaceuticals
ALNY
$40.3B
$24.5M 1.44%
74,000
+2,750
COGT icon
22
Cogent Biosciences
COGT
$5.97B
$24M 1.42%
624,155
-224,875
THC icon
23
Tenet Healthcare
THC
$15.1B
$23.6M 1.39%
125,000
DXCM icon
24
DexCom
DXCM
$28.5B
$22.3M 1.32%
355,600
+8,300
CLDX icon
25
Celldex Therapeutics
CLDX
$2.47B
$20.6M 1.22%
650,270
-42,268
1
2 3 4 5